Skadden Reps JLL Partners In $115M Health Buy-And-Build

Law360, New York (February 12, 2013, 5:13 PM EST) -- Private equity firm JLL Partners on Tuesday commenced a tender offer for BioClinica Inc. that values the manager of clinical trials at about $115 million and will allow it to be merged with another recently acquired health care company.

JLL Partners, a New York-based private equity firm with about $4 billion of capital and a focus on healthcare and pharma deals, will pay Pennsylvania-based BioClinica stockholders $7.25 per share. The tender offer follows a merger agreement signed Jan. 30.

JLL is also acquiring CoreLab Partners Inc., a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.